Today: 10 June 2026
Browse Category

NASDAQ:AKBA 1 December 2025

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio shares jumped as much as 170% intraday on December 1 after announcing the sale of its Phase 2 drug ADX-097 to Akebia Therapeutics for $12 million upfront and up to $592 million in milestones. Trading volume soared into the hundreds of millions. The company will now focus on its lead autoimmune drug, bempikibart, for alopecia areata.

Stock Market Today

  • India's Northeast Gas Pipeline Shortfall Costs ₹13 Crore Daily
    June 10, 2026, 9:58 AM EDT. India's gas producers, including Oil India, ONGC, and Vedanta, seek a temporary regulatory waiver from the Petroleum and Natural Gas Regulatory Board (PNGRB) to connect pipeline networks in the Northeast. A gap of less than 100 metres between pipelines legally prevents linking, stranding about 14 million metric standard cubic metres per day (MMSCMD) of domestic gas. This unused supply forces reliance on costly imported LNG at $19-$20 per million British thermal units (mmbtu), draining an estimated ₹13 crore daily. The Northeast grid's underdeveloped infrastructure-only 392 km of 1,688 km authorized pipelines operational-limits gas flow, threatening India's energy security strategy, which anticipates ₹410 billion investment in regional gas infrastructure. A provisional approval could unlock 6-8 MMSCMD in six weeks, easing supply shortages, industry sources told the Economic Times.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
Go toTop